All‐cause mortality – deaths · adults with or without existing CVD
High showed no clear difference in all‐cause mortality – deaths compared with low long‐chain omega‐3 fats (high certainty).
1 finding from 1 review
All‐cause mortality – deaths · adults with or without existing CVD
High showed no clear difference in all‐cause mortality – deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · adults with or without existing CVD
High showed no clear difference in cardiovascular mortality – cardiovascular deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Cardiovascular events · adults with or without existing CVD
High showed no clear difference in cardiovascular events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · adults with or without existing CVD
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
CHD events · adults with or without existing CVD
High showed no clear difference in coronary heart disease events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
1 finding from 1 review
Stroke · adults with or without existing CVD
It is very uncertain whether high changes stroke compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).
1 finding from 1 review
Arrhythmias · adults with or without existing CVD
High probably leads to lower arrhythmias compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Harms: bleeding · adults with or without existing CVD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Harms: pulmonary embolus or DVT · adults with or without existing CVD
It is very uncertain whether high changes harms: pulmonary embolus or DVT compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).
1 finding from 1 review
Outcomes All in trials of 12 to 72 months' duration · adults with or without existing CVD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · adults with or without existing CVD
High probably leads to lower cardiovascular mortality – cardiovascular deaths compared with low long‐chain omega‐3 fats (moderate certainty).
1 finding from 1 review
Measures of adiposity – LCn3 – Weight, kg · adults with or without existing CVD
1 finding from 1 review
Body‐mass index (BMI) · adults with or without existing CVD
2 findings from 1 review
Serum total cholesterol – LCn3 – TC, mmol/L · adults with or without existing CVD
1 finding from 1 review
Serum fasting triglyceride (TG, mmol/L) · adults with or without existing CVD
1 finding from 1 review
Serum high density lipoprotein – LCn3 – HDL, mmol/L · adults with or without existing CVD
1 finding from 1 review
Serum low‐density lipoprotein (LDL, mmol/L) · adults with or without existing CVD
2 findings from 1 review
Measures of adiposity – ALA – Weight, kg · adults with or without existing CVD
1 finding from 1 review
Serum total cholesterol – ALA – TC, mmol/L · adults with or without existing CVD
1 finding from 1 review